一心堂(002727) - 2022 Q1 - 季度财报

Financial Performance - Revenue for Q1 2022 reached ¥3,995,396,903.45, an increase of 16.53% compared to ¥3,428,551,312.20 in the same period last year[3] - Net profit attributable to shareholders was ¥179,380,370.34, a decrease of 31.17% from ¥260,630,426.63 year-on-year[3] - Cash flow from operating activities was ¥131,844,493.03, down 48.48% from ¥255,912,355.04 in the previous year[3] - The total operating costs for Q1 2022 were ¥3,795,097,759.61, up from ¥3,137,775,038.88 in the previous year, indicating a rise of about 20.9%[31] - The net profit for the current period is CNY 175,075,166.71, a decrease of 32.6% compared to CNY 259,964,241.59 in the previous period[34] - The total profit for the current period is CNY 209,312,960.76, down 28.2% from CNY 291,404,921.67 in the previous period[34] - Basic earnings per share for the current period is CNY 0.3039, down from CNY 0.4416 in the previous period[42] Cash Flow and Investments - Cash flow from investment activities turned negative at -$412.48 million, a decrease of 227.65% year-on-year[1] - The total cash outflow from investment activities was $697.77 million, down from $1.12 billion in the previous period, indicating a decrease of approximately 37.5%[50] - The net cash flow generated from investment activities was -$412.48 million, compared to a positive cash flow of $323.14 million in the prior period[50] - Cash inflow from financing activities amounted to $50 million, an increase from $17.97 million in the previous period[50] - The net cash flow from financing activities was -$263.04 million, an improvement from -$329.29 million in the previous period[50] - The beginning balance of cash and cash equivalents was $1.66 billion, up from $1.04 billion in the previous period[50] - The ending balance of cash and cash equivalents was $1.12 billion, down from $1.29 billion in the previous period[50] Assets and Liabilities - Total assets at the end of the reporting period were ¥14,498,046,678.44, reflecting a 1.12% increase from ¥14,337,349,279.85 at the end of the previous year[3] - As of the end of Q1 2022, the company's current assets totaled ¥7,839,216,055.93, compared to ¥7,692,379,928.77 at the beginning of the year, reflecting a slight increase[23] - The company's inventory stood at ¥3,268,667,415.88 at the end of Q1 2022, down from ¥3,316,964,090.61 at the start of the year[23] - The total liabilities decreased slightly from ¥7,664,801,674.77 at the beginning of the year to ¥7,652,790,762.86 by the end of Q1 2022[29] - The company's equity attributable to shareholders increased from ¥6,577,747,355.32 at the beginning of the year to ¥6,754,760,869.45 by the end of Q1 2022[29] Operational Challenges - The company faced operational challenges due to COVID-19, with nearly 500 stores temporarily closed and 2,146 stores required to remove certain products from sale due to pandemic control measures[19] - The company reported a cash flow impact from the pandemic, particularly affecting the reconciliation and collection of commercial insurance payments in Shanghai[19] - The company plans to gradually resume sales of previously removed products as pandemic control measures improve across various regions[19] - The company continues to enhance its retail chain network and operational capabilities to mitigate risks associated with the ongoing pandemic[19] Shareholder Information - The total number of common shareholders at the end of the reporting period was 40,361, with the largest shareholder holding 30.55%[2] - The largest shareholder, Ruan Hongxian, holds 30.55% of shares, with 44.94 million shares pledged[2] Store Expansion and Strategy - The company opened 298 new stores and closed 11, resulting in a net increase of 249 stores, bringing the total to 8,809[18] - The proportion of direct stores in townships reached 18.87%, indicating a focus on rural market expansion[18] - The company has a strategic plan for store expansion, aligning with its growth objectives[18] Research and Development - Research and development expenses decreased by 49.88% to ¥962,076.91, indicating reduced spending on R&D projects[8] - Research and development expenses decreased to CNY 962,076.91, down 50.0% from CNY 1,919,386.92 in the previous period[34] Other Income and Expenses - Other income rose by 126.08% to ¥16,316,787.80, primarily from increased VAT exemptions[8] - Sales expenses increased to CNY 1,002,415,085.74, up 18.9% from CNY 843,388,423.48 in the previous period[34] - The company experienced a 531.12% increase in credit impairment losses, amounting to -¥10,008,160.36, due to an increase in receivables[8] - The company recorded a loss in investment income of CNY 734,086.72 compared to a gain of CNY 9,222,832.44 in the previous period[34] Audit Status - The company’s first quarter report was not audited, indicating a potential area for investor scrutiny[51]